Literature DB >> 10620650

Blood pressure and the risk of cardiovascular disease.

S MacMahon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10620650     DOI： 10.1056/NEJM200001063420109

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Essential hypertension: the heart and hypertension.

Authors:  K E Berkin; S G Ball
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Antihypertensive drug therapy in the third millennium: are there benefits beyond blood pressure?

Authors:  S E Bakir; S Oparil
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 3.  Diastolic pressure, systolic pressure, or pulse pressure?

Authors:  C Vlachopoulos; M O'Rourke
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 4.  Endothelial dysfunction and the metabolic syndrome.

Authors:  Gary E McVeigh; Jay N Cohn
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 5.  Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?

Authors:  Irmgard Tegeder; Gerd Geisslinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-04       Impact factor: 3.000

6.  Personalised medicine, disease prevention, and the inverse care law: more harm than benefit?

Authors:  Jack E James
Journal:  Eur J Epidemiol       Date:  2014-04-12       Impact factor: 8.082

Review 7.  Application of Disease Etiology and Natural History to Prevention in Primary Health Care: A Discourse.

Authors:  Franklin White
Journal:  Med Princ Pract       Date:  2020-05-18       Impact factor: 1.927

Review 8.  Postmenopausal hypertension.

Authors:  L M Harrison-Bernard; L Raij
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

9.  The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs.

Authors:  Jarir Atthobari; Taco B M Monster; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

10.  Factors related to time to admission to specialized multidisciplinary clinics in patients with congestive heart failure.

Authors:  Debbie Ehrmann Feldman; Anique Ducharme; Marc Frenette; Nadia Giannetti; Caroline Michel; François Grondin; Richard Sheppard; Hassan Behlouli; Louise Pilote
Journal:  Can J Cardiol       Date:  2009-10       Impact factor: 5.223
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.